Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.

Bansal, Pankaj; Goyal, Amandeep; Cusick, Austin; Aslam, Fawad

Bansal, Pankaj; Goyal, Amandeep; Cusick, Austin; Aslam, Fawad.

Bansal P; Mayo Clinic Health System, Eau Claire, WI.
Goyal A; University of Kansas Medical Center, Kansas City, KS.
Cusick A; Ohio University Heritage College of Osteopathic Medicine, Athens, OH.
Aslam F; Mayo Clinic, Scottsdale, AZ.

Arthritis Rheumatol ; 73(3): 547-548, 2021 03.

Article in English | MEDLINE | ID: covidwho-1052833

Subject(s)

Arthritis, Psoriatic; COVID-19; Rheumatic Diseases; Rheumatology; Adult; Arthritis, Psoriatic/drug therapy; Humans; Pandemics; SARS-CoV-2; Thalidomide/analogs & derivatives; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatology / Arthritis, Psoriatic / Rheumatic Diseases / COVID-19 Limits: Adult / Humans Country/Region as subject: North America Language: English Journal: Arthritis Rheumatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google